Hims & Hers faced a significant stock drop after Novo Nordisk terminated their collaboration due to Hims offering its own version of semaglutide, potentially infringing on patents.
Source Post
A Stock a Day Until I Can Quit My Job: Day 12
Jul 2, 2025
This reel discusses Novo Nordisk, a Danish pharmaceutical company known for its weight loss drugs Ozempic and Wegovy. It touches on the company's market position, the controversy surrounding Hims & Hers selling its own version of semaglutide, and the FDA's stance on compounded drugs.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.